Glendora, California
United States
39
2025-10-09
The entities that hold a legal rights for patent applications filed by inventor Diamond Don J.:
Don J. Diamond from Glendora, US has applied for patents for these inventions. The list has both pending applications and granted patents:
SYNTHETIC MODIFIED VACCINIA ANKARA (SMVA) BASED CORONAVIRUS VACCINES
#2 | 2025-07-03POXVIRUS-BASED VECTORS PRODUCED BY NATURAL OR SYNTHETIC DNA AND USES THEREOF
#3 | 2024-06-27Use of endogenous viral vaccine in chimeric antigen receptor T cell therapy
#4 | 2024-03-14Chimeric Antigen Receptors against Human Cytomegalovirus
#5 | 2023-12-14MVA vaccine for delivery of a UL128 complex and preventing CMV infection
#6 | 2023-10-12SYNTHETIC MODIFIED VACCINIA ANKARA (SMVA) BASED CORONAVIRUS VACCINES
#7 | 2023-09-21GENETICALLY STABLE RECOMBINANT MODIFIED VACCINIA ANKARA (RMVA) VACCINES AND METHODS OF PREPARATION THEREOF
#8 | 2023-07-27SYNTHETIC MODIFIED VACCINIA ANKARA (sMVA) BASED CORONAVIRUS VACCINES
#9 | 2023-05-04Expression system for expressing herpesvirus glycoprotein complexes
#10 | 2023-03-30POXVIRUS-BASED VECTORS PRODUCED BY NATURAL OR SYNTHETIC DNA AND USES THEREOF
#11 | 2022-08-04ANTICANCER COMBINATIONS
#12 | 2022-06-23COMPOSITIONS AND METHODS FOR TARGETING TUMOR-ASSOCIATED EXTRACELLULAR MATRIX COMPONENTS TO IMPROVE DRUG DELIVERY
#13 | 2022-03-03Use of endogenous viral vaccine in chimeric antigen receptor T cell therapy
#14 | 2021-06-17MVA vaccine for delivery of a UL128 complex and preventing CMV infection
#15 | 2021-03-04Genetically modified recombinant vaccinia ankara (RMVA) vaccines of improved stability and methods of preparation thereof
#16 | 2021-03-04MVA VECTORS FOR EXPRESSING MULTIPLE CYTOMEGALOVIRUS (CMV) ANTIGENS AND USE THEREOF
#17 | 2020-08-06Synthetic conjugate of CpG DNA and T-help/CTL peptide
#18 | 2020-05-21Tumor associated vaccines and compositions for disrupting tumor-derived immunosuppression for use in combination cancer immunotherapy
#19 | 2020-05-21MVA-gH/gL-PC vaccine derived antibodies neutralizing human cytomegalovirus infectivity and methods thereof
#20 | 2020-05-21Expression system for expressing herpesvirus glycoprotein complexes
#21 | 2020-03-05MVA vaccine for delivery of a UL128 complex and preventing CMV infection
#22 | 2020-02-20Use of endogenous viral vaccine in chimeric antigen receptor T cell therapy
#23 | 2020-02-13P53-targeting vaccines and pd-1 pathway inhibitors and methods of use thereof
#24 | 2019-05-23Tumor associated vaccines and compositions for disrupting tumor-derived immunosuppression for use in combination cancer immunotherapy
#25 | 2018-10-25MVA vaccine for delivery of a UL128 complex and preventing CMV infection
#26 | 2018-08-30Synthetic conjugate of CpG DNA and T-help/CTL peptide
#27 | 2018-08-16MVA-gh/gL-PC vaccine derived antibodies neutralizing human cytomegalovirus infectivity and methods thereof
#28 | 2017-08-31RECOMBINANT LISTERIA STRAIN EXPRESSING HETEROLOGOUS ANTIGEN FUSION PROTEINS AND METHODS OF USE THEREOF
#29 | 2017-03-23Tumor associated vaccines and compositions for disrupting tumor-derived immunosuppression for use in combination cancer immunotherapy
#30 | 2016-06-30Anticancer combinations
#31 | 2016-01-07Synthetic conjugate of CpG DNA and T-help/CTL peptide
#32 | 2015-08-06MVA vaccine for delivery of a UL128 complex and preventing CMV infection
#33 | 2014-07-03Tumor associated vaccines and compositions for disrupting tumor-derived immunosuppression for use in combination cancer immunotherapy
#34 | 2007-09-27Modified vaccinia ankara expressing P53 in cancer immunotherapy
#35 | 2007-08-14Modified vaccinia Ankara expressing p53 in cancer immunotherapy
#36 | 2005-10-04CTL epitope analogs
#37 | 2005-07-21Synthetic conjugate of CpG DNA and T-help/CTL peptide
#38 | 2005-01-27Diagnostic reagents for human cytomegalovirus and methods of use
#39 | 2005-01-18Immuno-reactive peptide CTL epitopes of human cytomegalovirus
823503 ⎘